ERBB2 and breast cancer: Interestingly, the high PD-L1 expression in BC cell lines (i.e., MDA-MB-231 triple-negative and Her2-positive JIMT-1) seems not to be determined by the PD-L1 gene dose (i.e., an enhanced gene PD-L1 gene copy number).